Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and α-tocopherol: An experimental study

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 4, 1999, Pages 839-847

  Lefaix, Jean Louis ^a   Delanian, Sylvie ^a,b   Vozenin, Marie Catherine ^a   Leplat, Jean Jacques ^a   Tricaud, Yves ^a   Martin, Michéle ^a  

^a CEA SACLAY   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Alpha tocopherol ( tocopherol); Late radiation effects; Pentoxifylline; Radiation induced fibrosis; Transforming growth factor beta 1 (TGF 1); Tumor necrosis factor alpha (TNF )

Indexed keywords

ALPHA TOCOPHEROL; PENTOXIFYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FIBROSIS; GAMMA RADIATION; HISTOPATHOLOGY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INJURY; SCAR FORMATION; TREATMENT OUTCOME;

DRUG COMBINATIONS; FIBROSIS; GAMMA RAYS; HUMANS; MUSCLE, SKELETAL; PENTOXIFYLLINE; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; SKIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN E;

EID: 0033035813     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00419-2     Document Type: Article

References (57)

1. Archambeau J.O., Pezner R., Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys. 31:1995;1171-1185.
2. Bentzen S.M., Overgaard M. Clinical radiobiology and normal-tissue morbidity after breast cancer treatment. Adv Radiat Biol. 18:1994;25-51.
3. Dubray B., Delanian S., Lefaix J.-L. Late effects on skin and subcutaneous tissues after breast irradiation [in French]. Cancer Radiother. 1:1997;744-752.
4. Spanos W.J., Montague E., Fletcher G.H. Late complications of radiation only for advanced breast cancer. Int J Radiat Oncol Biol Phys. 6:1980;1473-1476.
5. Delanian S., Baillet F., Huart J., et al. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase Clinical trial . Radiother Oncol. 32:1994;12-20.
6. Lefaix J.-L., Daburon F. Diagnosis of acute localized irradiation lesions Review of the French experimental experience . Health Phys. 75:1998;375-384.
7. Lefaix J.-L., Martin M., Tricaud Y., et al. Muscular fibrosis induced after pig skin irradiation with single doses of 192 Ir gamma rays. Br J Radiol. 66:1993;537-544.
8. Lefaix J.-L., Daburon F., Martin M., et al. Irradiation γ and late effects The muscular fibrosis . [in French] Pathol Biol. 38:1990;617-625.
9. Rémy J., Wegrowski J., Crechet F., et al. Long term overproduction of collagen in radiation-induced fibrosis. Radiat Res. 125:1991;14-19.
10. Wegrowski J., Lefaix J.-L., Lafuma C. Accumulation of glycosaminoglycans in radiation-induced muscular fibrosis. Int J Radiat Biol. 61:1992;685-693.
11. Martin M., Rémy J., Daburon F. In vitro growth potential of pig fibroblasts isolated from radiation induced fibrosis. Int J Radiat Biol. 49:1986;821-828.
12. Martin M., Rémy J., Daburon F. Abnormal proliferation and aging of cultured fibroblasts from pig with subcutaneous fibrosis induced gamma irradiation. J Invest Dermatol. 93:1989;497-500.
13. Sabatier L., Martin M., Crechet F., et al. Chromosomal anomalies in radiation-induced fibrosis in the pig. Mut Res. 284:1992;257-263.
14. Martin M., Lefaix J.-L., Pinton P., et al. Temporal modulation of TGFβ1 and β-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res. 134:1993;63-70.
15. Martin M., Vozenin M.-C., Gault N., et al. Coactivation of AP-1 activity and TGFβ1 gene expression in the stress response of normal skin cells to ionizing radiation. Oncogene. 15:1997;981-989.
16. Lefaix J.-L., Delanian S., Leplat J.-J., et al. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD An experimental study . Int J Radiat Oncol Biol Phys. 35:1996;305-312.
17. Samlaska C.P., Winfield E.A. Pentoxifylline. J Am Acad Dermatol. 30:1994;603-621.
18. Dion M.W., Hussey D.H., Osborne J.W. The effect of pentoxifylline on early and late radiation injury following fractionated irradiation in C3H mice. Int J Radiat Oncol Biol Phys. 17:1989;101-107.
19. Dion M.W., Hussey D.H., Doornbos J.F., et al. Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int J Radiat Oncol Biol Phys. 19:1990;401-407.
20. Werner-Wasik M., Madoc-Jones H. Trental (pentoxifylline) relieves pain from postradiation fibrosis. Int J Radiat Oncol Biol Phys. 25:1993;757-758.
21. Futran N.D., Trotti A., Gwede C. Pentoxifylline in the treatment of radiation-related soft tissue injury Preliminary observations . Laryngoscope. 107:1997;391-395.
22. Baillet F. Alpha-tocopherol treatment of radio-fibrosis post-brachytherapy for breast cancer. (Abstr.) Radiother Oncol. 43:(Suppl. 1):1997;S3.
23. Delanian S., Lefaix J.-L. The association of pentoxifylline and tocopherol is useful in the treatment of human superficial radiation-induced fibrosis (RIF) Preliminary results . (Abstr.) Radiother Oncol. 40:(Suppl. 1):1996;S43.
24. Gottlöber P., Krähn G., Korting H.C., et al. Behandlung der kutanen Strahlenfibrose mit Pentoxifyllin und Vitamin E. [in German] Stralenther Onkol. 172:1996;34-38.
25. Lefaix J.-L., Daburon F., Fayart G. Dosimetry study of an accidental overexposure to 192Ir gamma rays. Health Phys. 63:1992;692-694.
26. Delanian S. Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol. Br J Radiol. 71:1998;892-894.
27. Monteiro D.T., Santamore W.P., Nemir P. The influence of pentoxifylline on skin flap survival. Plast Reconstr Surg. 77:1986;277-281.
28. Peterson T.C., Neumeister M. Effect of pentoxifylline in rat and swine models of hepatic fibrosis Role of fibroproliferation in its mechanism . Immunopharmacol. 31:1996;183-193.
29. Oberti F., Pilette C., Rifflet H., et al. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rat bile duct ligation. J Hepatol. 26:1997;1363-1371.
30. Park E.J., Ko G., Kim J., et al. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol Pharm Bull. 20:1997;417-420.
31. Entzian P., Gerlach C., Gerdes J., et al. Pentoxifylline inhibits experimental bleomycin-induced fibrosing alveolitis. Pneumology. 51:1997;375-380.
32. Hallahan D.E., Virudachalam J., Kuchibhotla J., et al. Molecular basis for the use of glucocorticoids, nonsteroidals and pentoxifylline to minimize the acute effects of radiotherapy. (Abstr.) Int J Radiat Oncol Biol Phys. 24:(Suppl. 1):1992;165-166.
33. Hong J.H., Chiang C.S., Campbell I.L., et al. Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys. 33:1995;619-626.
34. Koh W.J., Stelzer K.J., Peterson L.M., et al. Effect of pentoxifylline on radiation-induced lung and skin toxicity in rats. Int J Radiat Oncol Biol Phys. 31:1995;71-77.
35. Stelzer K.J., Koh W.J., Peterson L.M., et al. Effect of high dose pentoxifylline on acute radiation-induced lung toxicity in a rat lung perfusion model. Int J Radiat Oncol Biol Phys. 34:1996;111-115.
36. Ward W.F., Kim Y.T., Molteni A., et al. Pentoxifylline does not spare acute radiation reactions in rat lung and skin. Radiat Res. 129:1992;107-111.
37. Ward W.F., Molteni A., Ts'ao C.H., et al. Radiation pneumotoxicity in rats Modification by inhibitors of angiotensin converting enzyme . Int J Radiat Oncol Biol Phys. 22:1992;623-625.
38. Tamou S., Trott K.R. Modification of late radiation damage in the rectum of rats by deproteinized calf blood serum (ActoHorm) and pentoxifylline (PTX). Stralenther Onkol. 170:1994;415-420.
39. De Fraissinette A., Berman B., Duncan M.R., et al. Effects of pentoxifylline in interferon-γ and tumor necrosis factor-α induction of intercellular adhesion molecule-1 expression in human normal keratinocytes and Langerhans. Eur J Dermatol. 2:1992;265-272.
40. Berman B., Duncan M.R. Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Invest Dermatol. 92:1989;605-610.
41. Berman B., Duncan M.R. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol. 123:1990;339-346.
42. Chang C.C., Chang T.C., Kao C.S., et al. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema. Acta Endocrinol. 129:1993;322-327.
43. Duncan M.R., Berger R., Berman B. Pentoxifylline and interferon regulated mechanisms in inhibition of dermal fibroblast collagen synthesis. J Invest Dermatol. 100:1993;549.
44. Berman B., Wietzerbin J., Sanceau J., et al. Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts. J Invest Dermatol. 98:1992;706-712.
45. Duncan M.R., Hasan A., Berman B. Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts Evidence for mediation by nuclear factor 1 down-regulation . J Invest Dermatol. 104:1995;282-286.
46. Kilinc C., Ozcan O., Karaoz E., et al. Vitamin E reduces bleomycin-induced lung fibrosis in mice Biochemical and morphological studies . J Basic Clin Physiol Pharmacol. 4:1993;249-269.
47. Suntres Z.E., Shek P.N. Protective effect of liposomal alpha-tocopherol against bleomycin-induced lung injury. Biomed Environ Sci. 10:1997;47-59.
48. Denis M. Antioxidant therapy partially blocks immune-induced lung fibrosis. Inflammation. 19:1995;207-219.
49. Kuemmerle N.B., Brandt R.B., Chan W., et al. Inhibition of transforming growth factor beta 1 induction by dietary vitamin E in unilateral ureteral obstruction in rats. Biochem Molec Med. 61:1997;82-86.
50. Parola M., Muraca R., Dianzani I., et al. Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver. FEBS Lett. 308:1992;267-270.
51. Casini A., Ceni E., Salzano R., et al. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells Role of nitric oxide . Hepatology. 25:1997;361-367.
52. Rodrigues C.I., Hian-Njo K., Karim A.B.M.F. Results of radiotherapy and vitamin E in the treatment of Peyronie's disease. Int J Radiat Oncol Biol Phys. 31:1995;571-576.
53. Border W.A., Noble N.A. Transforming growth factor in tissue fibrosis. N Engl J Med. 331:1994;1286-1292.
54. Delanian S., Martin M., Bravard A., et al. Abnormal phenotype of cultured fibroblasts in human skin with chronic radiotherapy damage. Radiother Oncol. 47:1998;255-263.
55. Liochev S.I., Fridovich I. How does superoxide dismutase protect against tumor necrosis factor A hypothesis informed by effect of superoxide on "free" iron . Free Rad Biol Med. 23:1997;668-671.
56. Wong G., Elwell J., Oberley L., et al. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:1989;923-931.
57. Vozenin M.-C., Lefaix J.-L., Ridi R., et al. The myofibroblast markers α-SM actin and β-actin are differentially expressed in 2 and 3-D culture models of fibrotic and normal skin. Cytotechnology. 26:1998;29-38.